Clinical Trial Update: Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating antiandrogen therapy in combination with SBRT for recurrent or metastatic prostate cancer. The study status is active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Metastatic Prostate Adenocarcinoma, Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation | Phase 2 | Status: ACTIVE_NOT_RECRUITING